Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial

Heratizadeh, Annice; Werfel, Thomas; Wollenberg, Andreas; Abraham, Susanne; Plank-Habibi, S.; Schnopp, Christina; Sticherling, Michael; Apfelbacher, Christian; Biedermann, Tilo; Breuer, Kristine; Fell, I.; Fölster‐Holst, Regina; Heine, Guido; Grimm, Jennifer; Hennighausen, Lars; Kugler, Claudia; Reese, Imke; Ring, Johannes; Schäkel, Knut; Schmitt, Jochen; Seikowski, Kurt; Stebut, Esther von; Wagner, Nicola; Waßmann-Otto, Anja; Wienke-Graul, Ute; Weißhaar, Elke; Worm, Margitta; Gieler, Uwe; Kupfer, J.; Brauner, K.; Dölle, Sabine; Ehmann, Laura Maximiliane; Hagmaier, Ute; Eberlein, Susanne; Kroth, Julia; Lämmerhirt, Katja; Landleiter, Rosemarie; Lorenz, Ute; Lüdemann, Anja; Matterne, Uwe; Mitzel-Rink, Heidrun; Niebuhr, Margarete; Rehberg, Tessa; Vogel, S.; Wichmann, Katja

doi:10.1016/j.jaci.2017.01.029

Cited by 92 publications

(105 citation statements)

References 49 publications

Supporting

Mentioning

102

Contrasting

Unclassified

Order By: Relevance

“…The Pharmacist representative on the Panel noted concise directions written on the script can be reinforced at the time of dispensing and may further aid adherence. Structured educational programmes are of merit and can influence many aspects of patient care including coping behaviours and overall impact on QoL in adults with AD . Other delivery mechanisms include both Internet and face‐to‐face education, but only marginal consensus was reached on the most cost‐effective approach.…”

Section: Discussionmentioning

confidence: 99%

Atopic dermatitis in adults: An Australian management consensus

et al. 2019

View full text Add to dashboard Cite

Background/Objectives Atopic dermatitis (AD) has significant negative impact on health‐related quality of life, mood, sleep, work productivity and everyday activities. Research into the use of new drugs in the management of AD continues to develop, and international updates and recommendations have been published. However, questions remain in the Australian setting. This consensus aims to provide evidence‐based insights and practical advice on the management of adult AD in Australia. Methods A panel (five dermatologists and one clinical immunologist) met to review the literature, critically examine clinical questions of relevance to Australian healthcare practitioners and develop a series of recommendation statements. A consensus panel, comprising the initial panel plus nine additional members, used a 2‐round Delphi voting process to determine a set of final guidance statements. Consensus: ≥75% agreement in the range 7–9. Results Round 1 voting comprised 66 guidance statements. Of these, consensus was reached on 26, which were retained, and five were removed. The remainder (35) were modified and one new guidance statement was added for inclusion in round 2 voting. After round 2, consensus was reached on 35, which were retained, and one was removed (considered redundant). The 61 guidance statements upon which consensus was reached were then used to support a series of core consensus recommendations and a management flow chart. Conclusions Expert consensus recommendations providing practical guidance of clinical relevance to specialists and primary care physicians in Australia have been developed. Dissemination of this guidance and evaluation of its impact on patient outcomes remain to be undertaken.

show abstract

Section: Discussionmentioning

confidence: 99%

Atopic dermatitis in adults: An Australian management consensus

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Quality of life (QoL) is severely impaired in AE patients, as shown in a recent review: Statistically significant improvements in QoL of AE patients by patient education were reported in five studies, whereas the severity of skin disease improved significantly in three studies of ten studies evaluated. In conclusion, patient education appears to be effective in improving QoL and in reducing the perceived severity of skin disease . (See chapter: Educational interventions for AE).…”

Section: Psychosomatic Counsellingmentioning

confidence: 98%

“…There is evidence that structured age‐related programmes are significantly improving severity score, improving coping behaviour, parents handling their affected children and increasing disease knowledge . A recent multidisciplinary eczema school programme tailored to the adult situation showed also high efficacy …”

Section: Educational Interventions For Atopic Eczemamentioning

confidence: 99%

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Wollenberg

Barbarot

Bieber

et al. 2018

Acad Dermatol Venereol

557

717

View full text Add to dashboard Cite

This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic reviews and published studies into account. This second part of the guideline covers antimicrobial therapy, systemic treatment, allergen-specific immunotherapy, complementary medicine, psychosomatic counselling and educational interventions, whereas the first part covers methods, patient perspective, general measures and avoidance strategies, basic emollient treatment and bathing, dietary intervention, topical anti-inflammatory therapy, phototherapy and antipruritic therapy. Management of AE must consider the individual clinical variability of the disease. Systemic immunosuppressive treatment with cyclosporine, methotrexate, azathioprine and mycophenolic acid is established option for severe refractory cases, and widely available. Biologicals targeting the T helper 2 pathway such as dupilumab may be a safe and effective, disease-modifying alternative

show abstract

“…The routine of topical therapy requires time and effort, as well as steadiness and special skills by the patient. Accordingly, patients profit from educational programs [143, 144]. …”

Section: Therapeutic Management Of Admentioning

confidence: 99%

Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019

Simon

Wollenberg

Renz

et al. 2019

Int Arch Allergy Immunol

Self Cite

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a chronic inflammatory skin disease presenting with recurrent eczematous lesions and intense pruritus. It is common and affects both children and adults, often beginning in infancy. Due to the unpredictable disease course, its visible skin lesions, itching and scratching followed by sleeplessness, other associated atopic diseases, and behavioral and psychiatric disorders, AD is an immense burden for patients and caregivers. AD is determined by a genetic predisposition characterized by an impaired skin barrier and a T-helper-2-predominant inflammation. Restoration of the skin barrier is the main approach for treating and preventing AD. In order to cope with acute flares, usually topical corticosteroids (TCS) are applied, while topical calcineurin inhibitors (TCI) are used mainly for maintenance therapy. There is a small group of patients who are refractory to TCS and TCI and require systemic immunosuppressive drugs such as ciclosporin. Novel, targeted therapies are under clinical investigation, among which an anti-IL-4/IL-13 receptor antibody has recently been approved in several countries. As we learn to understand the pathomechanisms of AD, the characteristics of the different patient subgroups, and the effectiveness of various targeted therapies, a personalized treatment ensuring the best efficacy and safety and, probably, a disease-modifying effect will result.

show abstract

Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial

Cited by 92 publications

References 49 publications

Atopic dermatitis in adults: An Australian management consensus

Atopic dermatitis in adults: An Australian management consensus

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019

Contact Info

Product

Resources

About